Cargando…

Implantable Hearing Aids: Where are we in 2020?

Beginning in the late 20th century, implantable hearing aids were developed and used as an alternative for individuals who were unable to tolerate conventional hearing aids. Since that time, several devices have been developed, with four currently remaining on the international market (Med‐el Vibran...

Descripción completa

Detalles Bibliográficos
Autores principales: Banakis Hartl, Renee M., Jenkins, Herman A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752069/
https://www.ncbi.nlm.nih.gov/pubmed/33364411
http://dx.doi.org/10.1002/lio2.495
_version_ 1783625783360618496
author Banakis Hartl, Renee M.
Jenkins, Herman A.
author_facet Banakis Hartl, Renee M.
Jenkins, Herman A.
author_sort Banakis Hartl, Renee M.
collection PubMed
description Beginning in the late 20th century, implantable hearing aids were developed and used as an alternative for individuals who were unable to tolerate conventional hearing aids. Since that time, several devices have been developed, with four currently remaining on the international market (Med‐el Vibrant Soundbridge, Envoy Esteem, Ototronix MAXUM, and Cochlear Carina). This review will briefly examine the history of middle ear implant development, describe current available devices, evaluate the benefits and limits of the technology, and consider the future directions of research in the field of implantable hearing aids.
format Online
Article
Text
id pubmed-7752069
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-77520692020-12-23 Implantable Hearing Aids: Where are we in 2020? Banakis Hartl, Renee M. Jenkins, Herman A. Laryngoscope Investig Otolaryngol Otology, Neurotology, and Neuroscience Beginning in the late 20th century, implantable hearing aids were developed and used as an alternative for individuals who were unable to tolerate conventional hearing aids. Since that time, several devices have been developed, with four currently remaining on the international market (Med‐el Vibrant Soundbridge, Envoy Esteem, Ototronix MAXUM, and Cochlear Carina). This review will briefly examine the history of middle ear implant development, describe current available devices, evaluate the benefits and limits of the technology, and consider the future directions of research in the field of implantable hearing aids. John Wiley & Sons, Inc. 2020-11-06 /pmc/articles/PMC7752069/ /pubmed/33364411 http://dx.doi.org/10.1002/lio2.495 Text en © 2020 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Otology, Neurotology, and Neuroscience
Banakis Hartl, Renee M.
Jenkins, Herman A.
Implantable Hearing Aids: Where are we in 2020?
title Implantable Hearing Aids: Where are we in 2020?
title_full Implantable Hearing Aids: Where are we in 2020?
title_fullStr Implantable Hearing Aids: Where are we in 2020?
title_full_unstemmed Implantable Hearing Aids: Where are we in 2020?
title_short Implantable Hearing Aids: Where are we in 2020?
title_sort implantable hearing aids: where are we in 2020?
topic Otology, Neurotology, and Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752069/
https://www.ncbi.nlm.nih.gov/pubmed/33364411
http://dx.doi.org/10.1002/lio2.495
work_keys_str_mv AT banakishartlreneem implantablehearingaidswherearewein2020
AT jenkinshermana implantablehearingaidswherearewein2020